Fecal Microbiota Transplantation in Postoperative Crohn's Disease

Status: Recruiting
Location: See all (2) locations...
Intervention Type: Other
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY

This pilot study aims to detect possible trends or signals suggesting efficacy of FMT on prevention of delay of POR, to determine the safety of FMT in post operative CD, and asses if a full randomised controlled trial is feasible in this setting. With microbiota analysis we aim to assess if changes in gut microbiota are related to disease course of CD after operation.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Maximum Age: 120
Healthy Volunteers: f
View:

• Over 18 years

• Able to provide written consent

• Stricturing and/or fistulizing Crohn's disease needing ileocecal or ileal resection

Locations
Other Locations
Finland
Tampere University Hospital
RECRUITING
Tampere
Tampere University Hospital
RECRUITING
Tampere
Contact Information
Primary
Elina Jokinen, PhD
elina.jokinen@pshp.fi
+3583311611
Time Frame
Start Date: 2021-05-18
Estimated Completion Date: 2027-12
Participants
Target number of participants: 20
Treatments
Active_comparator: Fecal Microbiota Transplantation
Placebo_comparator: Plasebo
Sponsors
Leads: Tampere University Hospital
Collaborators: Joint Authority for Päijät-Häme Social and Health Care, Helsinki University Central Hospital, Turku University Hospital, Tampere University, Kuopio University Hospital

This content was sourced from clinicaltrials.gov